Results of two European interlaboratory studies for the determination of β-agonists in various matrices†

Abstract

Two Beta-Agonist Interlaboratory Studies, 5/96 and 11/97, were designed and evaluated according to the International Harmonised Protocol for the Proficiency Testing of (Chemical) Analytical Laboratories (ISO/REMCO N 280) jointly elaborated by ISO, IUPAC and AOAC. In the sense of proficiency testing, interlaboratory studies are part of external quality assurance systems. The Beta-Agonist Interlaboratory Studies 5/96 and 11/97 were intended to offer laboratories in the EU Member States an opportunity to check objectively their routine methods for the detection of β-agonists and to demonstrate the reliability of their analytical results; 48 and 44 laboratories, respectively, all involved in official residue control, participated in the studies. Irrespective of the large number of satisfactory results achieved at higher concentration levels according to the z-score evaluation, the number of false negative results is still unsatisfactory. The results of both Beta-Agonist Interlaboratory Studies confirmed that comparability of analytical results is not yet ensured within the European residue control system.

References

1. EEC Council Directive 96/23, Off. J. Eur. Commun., 1996, No. L 125/10.
2. EEC Commission Decision 98/179, Off. J. Eur. Commun., 1998, No. L 65/31.
3. ISO/REMCO N 280, Pure Appl. Chem., 1993, 9, 2123.
4. S. Uhlig, Entwicklung eines Programms zur Auswertung von anal. Laborvergleichsuntersuchungen gemäss int. Protokollen: Mathematisch-statistische Konzeption, Bericht im Rahmen eines BgVV-Projekts, Berlin, 1995.
5. H. Horwitz, L. R. Kamps and K. W. Boyer, J. Assoc. Off. Anal. Chem., 1980, 6, 1344.
6. P. J. Rousseeuw and C. Croux, J. Am. Stat. Assoc., 1993, 88, 1273.
7. EEC Commission Decision 93/256, Off. J. Eur. Commun., 1993, No. L 118/64.